parp inhibitors: activity in brca1 versus brca2 altered mcrpc
Published 3 years ago • 234 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
2:48
assessing parp inhibition and brca1/2 as a prognostic biomarker in mcrpc
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
12:07
parp inhibitors in brca1/2-mutated patients in prostate cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
6:21
parp inhibition in brca1/2 or hrd- ovarian cancer
-
1:02
where can parp inhibitors be used
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
0:27
parp inhibitors #short
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
3:13
impact of specific mutations on parp inhibition in prostate cancer
-
16:22
role of parp inhibitors in prostate cancer
-
35:38
parp inhibitor combination regimens for prostate cancer management
-
0:46
parp inhibitor rechallenging in ovarian cancer
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
1:08
should 1l maintenance with parp inhibitors be given to all patients with ovarian cancer?
-
47:27
parp inhibitors: a breakthrough in cancer therapy?
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...